日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The Repurposing of FDA-Approved Drugs as FtsZ Inhibitors against Mycobacterium tuberculosis: An In Silico and In Vitro Study

将 FDA 批准的药物重新用作抗结核分枝杆菌的 FtsZ 抑制剂：一项计算机模拟和体外研究

期刊:Microorganisms
影响因子:4.1
doi:10.3390/microorganisms12081505
Andrea Michel Tovar-Nieto, Luis Enrique Flores-Padilla, Bruno Rivas-Santiago, Juan Valentin Trujillo-Paez, Edgar Eduardo Lara-Ramirez, Yolanda M Jacobo-Delgado, Juan Ernesto López-Ramos, Adrián Rodríguez-Carlos
免疫
发表日期：2024
文献求助 收藏

Histone deacetylase (HDAC) inhibitors- based drugs are effective to control Mycobacterium tuberculosis infection and promote the sensibility for rifampicin in MDR strain

组蛋白去乙酰化酶 (HDAC) 抑制剂类药物可有效控制结核分枝杆菌感染，并提高 MDR 菌株对利福平的敏感性

期刊:Memorias Do Instituto Oswaldo Cruz
影响因子:2.5
doi:10.1590/0074-02760230143
Adrián Rodríguez-Carlos, Yolanda Jacobo-Delgado, Alan Orlando Santos-Mena, Mariana H García-Hernández, Luis Adrian De Jesus-Gonzalez, Edgar E Lara-Ramirez, Bruno Rivas-Santiago
表观遗传
H3
发表日期：2023
文献求助 收藏

Near-Infrared Fluorescent Probes with Amine-Incorporated Xanthene Platforms for the Detection of Hypoxia

用于检测缺氧的含胺呫吨平台近红外荧光探针

期刊:ACS Applied Bio Materials
影响因子:4.7
doi:10.1021/acsabm.2c00493
Wan, Shulin; Vohs, Tara; Steenwinkel, Tessa E; White, Walter Reynolds; Lara-Ramirez, Adrian; Luck, Rudy L; Werner, Thomas; Tanasova, Marina; Liu, Haiying
IF
发表日期：2022
文献求助 收藏

Repositioning FDA Drugs as Potential Cruzain Inhibitors from Trypanosoma cruzi: Virtual Screening, In Vitro and In Vivo Studies

将FDA批准的药物重新定位为潜在的克氏锥虫克氏蛋白酶抑制剂：虚拟筛选、体外和体内研究

期刊:Molecules
影响因子:4.6
doi:10.3390/molecules22061015
Palos, Isidro; Lara-Ramirez, Edgar E; Lopez-Cedillo, Julio Cesar; Garcia-Perez, Carlos; Kashif, Muhammad; Bocanegra-Garcia, Virgilio; Nogueda-Torres, Benjamin; Rivera, Gildardo
发表日期：2017
文献求助 收藏